| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Z-FA-FMK | 197855-65-5 | sc-201303 sc-201303A | 1 mg 5 mg | $128.00 $372.00 | 19 | |
Z-FA-FMK is a fluoromethylketone-based inhibitor that forms a covalent bond with the active site of CTSV, rendering it inactive. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
K11777 is a potent, irreversible peptidyl inhibitor, targeting the active site of CTSV and preventing its protease function. | ||||||
CA-074 | 134448-10-5 | sc-202513 | 1 mg | $321.00 | ||
CA-074 is a selective, irreversible inhibitor of CTSV, specifically targeting and modifying its active site cysteine residue. | ||||||
MDL-28170 | 88191-84-8 | sc-201301 sc-201301A sc-201301B sc-201301C | 10 mg 50 mg 100 mg 500 mg | $69.00 $241.00 $447.00 $2195.00 | 20 | |
MDL-28170 is a broad-spectrum cysteine protease inhibitor, with a particular affinity for inhibiting CTSV through active site interaction. | ||||||
VX-765 | 273404-37-8 | sc-475845 sc-475845A sc-475845B | 5 mg 10 mg 50 mg | $228.00 $302.00 $968.00 | 1 | |
VX-765, also known as Belnacasan, is a prodrug that is metabolized into a potent inhibitor of CTSV, effectively blocking its protease activity. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin Hemisulfate is a reversible inhibitor that binds to the active site of CTSV, thereby inhibiting its proteolytic function. | ||||||
SID 26681509 | 958772-66-2 | sc-361358 sc-361358A | 10 mg 50 mg | $421.00 $1569.00 | 1 | |
SID 26681509 acts as a competitive inhibitor of CTSV, binding to its active site and preventing substrate access. | ||||||
Odanacatib | 603139-19-1 | sc-364675 sc-364675A sc-364675B | 5 mg 25 mg 250 mg | $218.00 $993.00 $1982.00 | 2 | |
Odanacatib selectively inhibits CTSV by binding to its active site, thereby reducing its protease activity without affecting other cathepsins. | ||||||
Tris(dibenzylideneacetone)dipalladium(0) | 51364-51-3 | sc-253790 sc-253790A sc-253790B sc-253790C | 500 mg 1 g 10 g 50 g | $56.00 $107.00 $629.00 $3124.00 | ||
This chloromethyl ketone derivative acts as an irreversible inhibitor of CTSV by modifying its active site cysteine residue. | ||||||